Navigation Links
Technology for monitoring fetal oxygen during labor offers no apparent benefit

hnique's effectiveness.

The authors of the current study undertook their research to try to find if there was sufficient reason to warrant introducing fetal oxygen saturation monitoring into the delivery room. A previous study of the technology was inconclusive. That study found no overall change in Caesarean delivery rates when fetal oxygen saturation monitoring was undertaken. However, the study found different rates of Caesarean deliveries for two different categories of births. For cases in which the fetal heart rate pattern was abnormal, there were fewer Caesarean deliveries than normal. But there was a higher-than-normal rate of Caesarean deliveries from cases involving dystocia--failure of the baby to move down the birth canal. (Dystocia can result from such causes as the baby being improperly positioned in the birth canal, or from the baby simply being too large.)

Because the results of that earlier study were inconclusive, the U.S. Food and Drug Administration, which approves new medical devices for safety and effectiveness, granted only provisional approval for fetal oxygen saturation monitoring until the new technology could be proven effective. The current study was designed to settle unresolved questions about the new technology.

With fetal oxygen saturation monitoring, a sensor is inserted by hand through the cervix, after the membranes have ruptured, and placed against the baby's face. The sensor, connected to a monitor by a cable, provides a continuous reading of the baby's oxygen level.

For the current study, the researchers enrolled 5341women from 14 hospitals throughout the United States. The women were randomly assigned to one of two groups: an "open" group, in which oxygen levels were continuously monitored, and a "masked" group, in which oxygen levels did not appear on a monitor and were not revealed to birth attendants. Of the pregnant women who participated, 2629 were randomly assigned to the
'"/>

Source:NIH/National Institute of Child Health and Human Development


Page: 1 2 3

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
3. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
4. Technology exists to keep E. coli out of food
5. Technology reveals lock and key proteins behind diseases
6. Alaskan puzzles, monitoring provide insight about North Pacific salmon runs
7. MERIS monitoring tracks planetary photosynthesis levels
8. Carnegie Mellon cyLab researchers work to develop new red tide monitoring
9. Software might revolutionize glucose monitoring in critically ill patients
10. Cardiologists living chip changes science of disease monitoring
11. A revolution in the monitoring of unborn babies

Post Your Comments:
(Date:12/1/2009)...is release is available in German . , Brown a... contains loads of mitochondria, miniature power ...In doing this, they normally generate a voltage si...ergy for cellular processes. However, the mitochon... go full steam ahead all the time. The energy rele...
(Date:12/1/2009)...ezkel Ben-Ari, winner of the 2009 Inserm Grand Pri...ts commitment to paying tribute to outstanding,wo...By honouring talents, Inserm intends to,demonstra... in today,s biological, medical and,health resear...women who carry out and,drive this research each ...
(Date:12/1/2009)... , NEW YORK, Dec. 1 iQor, a ...PO) services, was included in the 2009 InfoWorld ...metric-enabled ERP system, TeQ21. This was the fir...e recognized among this prestigious list of compan.... "TeQ21 is completely transforming the way we do ...
Breaking Biology News(10 mins):Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2New theory on why male female lemurs same size 9258 1New theory on why male female lemurs same size 9258 2New theory on why male female lemurs same size 9258 3Endoscopic Technologies to Pay U S 241 4 Million to Resolve Allegations of Medicare Fraud 51655 1Endoscopic Technologies to Pay U S 241 4 Million to Resolve Allegations of Medicare Fraud 51655 2MUSC Earns 2420 Million Award From National Institutes of Health 51650 1MUSC Earns 2420 Million Award From National Institutes of Health 51650 2MUSC Earns 2420 Million Award From National Institutes of Health 51650 3
...when we were paralyzed in the face of a tough deci... right choice can mean the difference between life...the thing that leads to a "reward," such as food, ...ng and understanding those changes has been the fo...ouncil (NSERC) grantee Peter Shizgal for most of h...
...ay be out of date now that University of Florida s... on a South Pacific island. , New genera of livin...ear is announced globally. David Steadman and Andr...f Natural History, turned up the surprising new di...Islands. Theirs is the first frogmouth from these ...
...ften cause dramatic symptoms such as the formation...eeds. Some fungi can even make infected plants sme... cause major headaches for farmers who are countin...vive through the growing season. , Natural Scien...ee James Kronstad has spent almost his entire life...
Other Biology News:Rewarding fat rats 2UF scientists discover new genus of frogmouth bird in Solomon Islands 2UF scientists discover new genus of frogmouth bird in Solomon Islands 3Stopping plants from getting sick 2
(Date:12/1/2009)..., NEW YORK and MONTREAL, Dec. 1 /PRNewswire-FirstC...-ICBS Ltd. (OTCPK: ICBT), announced today that the...facturing Inc., of Canada for the manufacturing of...ution in the U.S. ,, "We have seen the disastro...h vegetables and packaged salads in the past" said...
(Date:12/1/2009)... iCardiac now provides services to...anies. , Rochester, NY (P...nc., a global leader in advanced cardiac core lab ...op five pharmaceutical company has selected iCardi... iCardiac will provide Highly Automated QT(sm) an...
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswi...mpany specializing in interactive marketing servi...ay announced the launch of its HATCH Consulting ...tch ). Aligning strategic experts across a range ..., the HATCH Consulting team is committed to guidin...
(Date:11/30/2009)..., AMSTERDAM, November 30 Bio...ay that the first patients have been enrolled in i...ATIR(TM). The study is,designed to show reduction ...ar following an allogeneic stem cell transplantati...ood cancer patients eligible for an allogeneic,ste...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2
...e 25 Kelo-cote(R) advanced formula,scar gel is a ...technology,and has become the gold standard for sc...ented silicone formula in Kelo-cote(R) advanced fo...-Technologies, Inc.(ABT)., Kelo-cote(R) is no lon...d customers should not be misled by competitors, c...
... Leading baked goods manufacturer chooses pro...n bran probiotic muffins. , ...n Street Gourmet, one of the fastest growing manuf...troduced Activate -- a new raisin bran muffin fort...denBC30 (Bacillus coagulans GBI-30, 6086). The ne...
...June 25 Lixte,Biotechnology Holdings (OTC Bulleti...nstitute of Neurological Disorders and Stroke (NIN... Biotechnology Holdings, Inc. extended,their Coope...to develop,drugs for the treatment of brain cancer... through September 2009., Dr. John S. Kovach, Pre...
Other Biology Technology:Main Street Gourmet Launches New Probiotic Muffins 2Main Street Gourmet Launches New Probiotic Muffins 3Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 2Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs 3
REact 2 Buffer from Invitrogen
Phosphate Colorimetric Assay Kit from R&D Systems
Feline IL-10 ELISpot Development Kit from R&D Systems
Feline IL-2 ELISpot Development Kit from R&D Systems
Biology Products: